Skip to main navigation Skip to search Skip to main content

Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod

Claus Michael Gross, Annette Baumgartner, Sebastian Rauer, Oliver Stich*

*Corresponding author for this work
Original languageEnglish
JournalNeurology
Volume79
Issue number19
Pages (from-to)2006-2007
Number of pages2
ISSN0028-3878
DOIs
Publication statusPublished - 06.11.2012

Funding

Study funding: The patient reported here participated in the TRANSFORMS trial sponsored by Novartis AG, Switzerland. The sponsor permitted submission of this case.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Health Sciences

DFG Research Classification Scheme

  • 2.23-08 Human Cognitive and Systems Neuroscience
  • 2.22-31 Clinical Infectiology and Tropical Medicine

Cite this